Which university are you at? kegunaan celebrex 100 mg ASTERIA I is the final pivotal registration study for omalizumab in CSU to be announced. Results of the study were presented Saturday for the first time at the 22nd Congress of the European Association of Dermatology and Venereology or EADV in Istanbul, Turkey.